Last reviewed · How we verify

NCT04067791

A Study to Investigate the Pharmacokinetics of Prolonged-release Melatonin Compared to Standard, Immediate-release Melatonin in Healthy Adults

Completed Phase 1 Last updated 9 June 2020
What this trial tests

Phase 1 trial testing Prolonged-Release Melatonin in Healthy in 18 participants. Completed in 27 August 2019.

Timeline
1 August 2019
Primary endpoint
27 August 2019
27 August 2019

Quick facts

Lead sponsorPharmavite LLC
PhasePhase 1
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designcrossover
Maskingquadruple
Primary purposeother
Enrollment18
Start date1 August 2019
Primary completion27 August 2019
Estimated completion27 August 2019
Sites1 location across Canada

Drugs / interventions tested

Conditions studied

Sponsor

Pharmavite LLC — full company profile →

Who can join

Adults 18 to 65, any sex, with Healthy. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

A study comparing the pharmacokinetics of prolonged-release melatonin versus standard, immediate-release melatonin. Multiple blood draws over a 10-hour period will be analysed to determine the area under the curve, time to peak concentration, peak concentration, absorption rate constant, elimination rate constant, absorption half-life, and elimination half-life. Vital signs, hematology parameters, clinical chemistry parameters, and incidence of adverse events are also analysed.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. A Randomized, Double-Blind, Crossover Study to Investigate the Pharmacokinetics of Extended-Release Melatonin Compared to Immediate-Release Melatonin in Healthy Adults.
    Mun JG, Wang D, Doerflein Fulk DL, Fakhary M, et al · · 2024 · cited 6× · PMID 37150895 · DOI 10.1080/19390211.2023.2206475

Verify or expand the search:

Other recruiting trials for Healthy

Currently open trials in the same condition.

Other Pharmavite LLC trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04067791.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing